June 20, 2025

FDA Approves First Twice-Yearly Injectable PrEP

FDA approved the first biannual injectable PrEP option, Yeztugo (lenacapavir), after studies showed it prevented HIV infection in over 99.9% of participants.

Conexiant

June 18, 2025

Medical Oddities: The Silver Lining in Loneliness

Loneliness flips the script—plus surprises from tea, tech, toxins, and a spicy twist.

Conexiant

June 18, 2025

Are CBD Compounds Effective Antifungals?

CBD and CBDV exhibit antifungal activity against Cryptococcus neoformans and dermatophytes in vitro and improve survival in an in vivo model.

Conexiant

June 18, 2025

Short on Docs, NPs Fill the Gap

As America’s older adult population grows and geriatricians retire, nurse practitioners are stepping up to provide essential, compassionate care—often in patients’ homes.

KFF Health News

June 17, 2025

Anal Cancer Screening Cost-Effective at 35

A large modeling study evaluated the cost-effectiveness, benefits, and harms of anal cancer screening strategies for men who have sex with men living with HIV.

Conexiant

June 16, 2025

Sacituzumab Govitecan and Pembrolizumab Improve Disease Control in Advanced PD-L1–Positive Triple-Negative Breast Cancer

Results from an international phase III clinical trial show that treatment with sacituzumab govitecan and pembrolizumab helps patients with unresectable, locally advanced or metastatic PD-L1–positive ...

The ASCO Post

June 16, 2025

Updated Guidance on Antirheumatic Drug Use

New 2024 EULAR recommendations offer evidence-based guidance for the use of antirheumatic drugs during pregnancy, lactation, and conception planning in patients with rheumatic and musculoskeletal diseases.

Conexiant

June 13, 2025

RSV Vaccine Approved for Younger Adults

The FDA has approved Moderna’s mRESVIA vaccine for adults aged 18 to 59 who are at increased risk for RSV, expanding its indication beyond older adults.

Conexiant

June 13, 2025

Experts: HHS Sent Congress ‘Junk Science’

A controversial HHS document supporting RFK Jr.'s rollback of COVID vaccine guidance relies on disputed or misrepresented science, prompting outrage from health experts who call it “willful medical disinformation.”

KFF Health News